Physician

Daniel Vanroy, MD

According to 2025 Medicare claims, Daniel Vanroy, MD (NPI: 1740236330) practices interventional cardiology in the Gainesville, FL market, with the plurality of this provider's patient population coming from Alachua, FL. This provider's primary affiliated billing organization is INTERVENTIONAL CARDIOLOGISTS OF GAINESVILLE, PA (NPI: 1811931629; TIN: 591536350) and primary practice location at 32605-4218.

Vanroy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,459 traditional Medicare patients, billed 6,730 HCPCS/CPT codes, and received $748,804 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 3,583 prescription claims across 621 beneficiaries totaling $760,738 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 24 claims. Open Payments data shows 62 records totaling $12,765. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $1,067,516 to $748,804. In contrast, Part D prescription costs have moved sharply higher in recent years, from $145,206 to $760,738. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,979	35,399	$1,067,516
2016	2,102	37,889	$1,163,693
2017	2,110	27,295	$1,316,515
2018	1,904	18,985	$1,149,464
2019	2,118	7,723	$1,157,855
2020	2,077	6,854	$868,742
2021	1,914	7,351	$877,457
2022	1,711	6,678	$687,941
2023	1,968	8,760	$887,819
2024	1,459	6,730	$748,804

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	372	2,923	$145,206
2016	392	3,052	$178,193
2017	417	2,720	$178,517
2018	406	2,314	$244,615
2019	402	2,282	$286,822
2020	450	2,418	$350,953
2021	487	2,749	$448,182
2022	492	2,903	$550,389
2023	546	2,925	$628,292
2024	621	3,583	$760,738

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	24	$1,082
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	368	369	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	550	667	$94
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	188	189	$51
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	453	544	$12
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	768	914	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	300	16,652	$320,577
Entresto	Sacubitril/Valsartan	92	5,548	$108,845
Xarelto	Rivaroxaban	111	5,433	$99,025
Jardiance	Empagliflozin	49	2,910	$56,607
Repatha Sureclick	Evolocumab	41	1,888	$36,863

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	60	$5,165	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$7,600	Terumo Medical Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Vanroy, MD?

Tedicare shows public-source Medicare data for Daniel Vanroy, MD (NPI 1740236330), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Vanroy, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel Vanroy, MD?

Daniel Vanroy, MD is linked to INTERVENTIONAL CARDIOLOGISTS OF GAINESVILLE, PA (billing NPI 1811931629) in the available physician profile data.

Does Daniel Vanroy, MD have Open Payments data?

Daniel Vanroy, MD has 62 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.